Complete Up To Date Information about Component TE-IS.
ANADA Number: 200-221 | |
| Proprietary Name |
Component® TE-IS Component® TE-S Component® TE-G Component® TE-ID with Tylan® Component® TE-IS with Tylan® Component® TE-S with Tylan® Component® TE-G with Tylan® |
|---|---|
| Sponsor |
Ivy Laboratories, Division of Ivy Animal Health, Inc. |
| Sponsor Address |
8857 Bond Street Overland Park, KS 66214 USA |
| Ingredients |
Tylosin Tartrate Estradiol Trenbolone Acetate |
| Species |
Cattle, pastured (slaughter, stocker, feeder, beef and heifers)
beef replacement heifers Cattle, beef, steers fed in confinement for slaughter, excluding veal |
| Routes of Administration |
Subcutaneous |
| Dose Form |
Implant (pellet) |
| Drug Form |
Implant (pellet) |
| Dispensing Status |
OTC |
| Patent Number |
5874098 |
| Exclusivity |
Granted for the addition of the tylosin tartrate pellet as a local antibacterial to Component? TE-IS. Adds tylosin as a local antibacterial for control of injection site infections Granted for the addition of tylosin tartrate in use in pasture cattle for increased rate of weight gain. |
| Withdrawal Time |
Cattle: zero days before slaughter. |
|
Dosage Amount, Indications & Limitations |
522.2477 Trenbolone acetate and estradiol. Specifications: No specifications are included in the CFR for this product. Conditions of use: Cattle (steers fed in confinement for slaughter excluding veal) Amount: 80 milligrams (mg) trenbolone acetate and 16 mg estradiol (one implant consisting of 4 pellets, each pellet containing 20 mg trenbolone acetate and 4 mg estradiol) per implant dose. Indications: For increased rate of weight gain and improved feed efficiency. Limitations: Implant subcutaneously in ear only. Do not use in animals intended for subsequent breeding or in dairy animals. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Amount: 120 milligrams (mg) trenbolone acetate and 24 mg estradiol (one implant consisting of 6 pellets, each pellet containing 20 mg trenbolone acetate and 4 mg estradiol) per implant dose. Indications: For increased rate of weight gain and improved feed efficiency. Limitations: Implant subcutaneously in ear only. Do not use in animals intended for subsequent breeding or in dairy animals. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Amount: 80 mg trenbolone acetate and 16 mg estradiol (one implant consisting of 5 pellets, each of 4 pellets containing 20 mg trenbolone acetate and 4 mg estradiol, and 1 pellet containing 29 mg tylosin tartrate) per implant dose. Indications: For increased rate of weight gain and improved feed efficiency. Limitations: Implant subcutaneously in ear only. Do not use in animals intended for subsequent breeding or in dairy animals. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. Cattle (slaughter, stocker, feeder steers, and heifers) Amount: 40 mg trenbolone acetate and 8 mg estradiol (one implant consisting of 2 pellets, each pellet containing 20 mg trenbolone acetate and 4 mg estradiol) per implant dose. Indications: For increased rate of weight gain. Limitations: Implant subcutaneously in ear only. Do not use in animals intended for subsequent breeding or in dairy animals. Safety and effectiveness have not been established in veal calves. A withdrawal period has not been established for this product in preruminating calves. Do not use in calves to be processed for veal. |
| Tolerances |
A tolerance for total trenbolone residues in uncooked edible tissues of cattle is not needed. No residues of estradiol, resulting from the use of estradiol or any of the related esters, are permitted in excess of the following increments above the concentrations of estradiol naturally present in untreated animals: a. In uncooked edible tissues of heifers, steers, and calves: (1) 120 parts per trillion for muscle (2) 480 parts per trillion for fat (3) 360 parts per trillion for kidney (4) 240 parts per trillion for liver b. In uncooked edible tissues of lambs: (1) 120 parts per trillion for muscle (2) 600 parts per trillion for fat, kidney, and liver Tolerances are established for residues of tylosin in edible products of animals as follows: a. Chickens and turkeys: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. b. Cattle: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. c. Swine: 0.2 part per million (negligible residue) in uncooked fat, muscle, liver, and kidney. d. Milk: 0.05 part per million (negligible residue). e. Eggs: 0.2 part per million (negligible residue). |